[68Ga]Ga-DOTATATE与[68Ga]Ga-FAPI PET/CT在鼻咽癌患者中的头对头比较:一项单中心前瞻性研究
39例病理确诊鼻咽癌患者连续两天分别行[68Ga]Ga-DOTATATE与[68Ga]Ga-FAPI PET/CT,以头颈部MRI、病理和随访为参考标准比较TNM分期效能。[68Ga]Ga-DOTATATE对原发灶显示更清晰,对颈部淋巴结转移和远处转移(尤其骨转移)的灵敏度和准确率更高,提示其用于鼻咽癌分期可能优于[68Ga]Ga-FAPI。
要点
- 初治患者中[68Ga]Ga-DOTATATE原发灶灵敏度与[68Ga]Ga-FAPI相同,但肿瘤/本底比值更高(19.1±8.7 vs 12.4±7.7,P=0.003)。
- 颈部淋巴结转移:按颈侧、颈区、单个淋巴结分析,[68Ga]Ga-DOTATATE灵敏度和准确率均显著高于[68Ga]Ga-FAPI。
- 远处转移尤其骨转移:[68Ga]Ga-DOTATATE灵敏度与准确率显著高于[68Ga]Ga-FAPI;治疗后患者中多识别1例真阴性。
核心结论
- [68Ga]Ga-DOTATATE PET/CT在显示原发肿瘤、检测转移灶和识别局部复发方面优于[68Ga]Ga-FAPI PET/CT,提示其用于鼻咽癌分期可能优于[68Ga]Ga-FAPI PET/CT。
研究设计与样本
- 单中心前瞻性研究,纳入39例病理确诊的鼻咽癌患者。
- 每例患者连续2天分别行[68Ga]Ga-DOTATATE与[68Ga]Ga-FAPI PET/CT配对检查。
- 以头颈部MRI、组织病理学诊断和随访结果作为参考标准,比较两种PET/CT评估T、N、M分期的准确性,并比较两种示踪剂的摄取。
主要发现
- 初治患者中,[68Ga]Ga-DOTATATE PET/CT对原发肿瘤的灵敏度与[68Ga]Ga-FAPI PET/CT相同,但肿瘤/本底比值更高(19.1±8.7 vs 12.4±7.7,P=0.003),肿瘤勾画更清晰。
- 颈部淋巴结转移按颈侧分析:[68Ga]Ga-DOTATATE灵敏度98% vs [68Ga]Ga-FAPI 82%(P<0.001),准确率99% vs 88%(P=0.008)。
- 颈部淋巴结转移按颈区分析:灵敏度98% vs 78%,准确率99% vs 97%(均P<0.001);按单个淋巴结分析:灵敏度89% vs 56%,准确率91% vs 76%(均P<0.001);肿瘤/本底比值8.1±4.1 vs 6.3±3.7(P<0.001)。
- 远处转移:[68Ga]Ga-DOTATATE灵敏度96% vs [68Ga]Ga-FAPI 53%,准确率95% vs 52%(均P<0.001);骨转移灵敏度99% vs 49%,准确率97% vs 49%(均P<0.001)。
- 治疗后患者中,[68Ga]Ga-DOTATATE PET/CT较[68Ga]Ga-FAPI PET/CT多识别1例真阴性病例。
临床怎么用
- 作者认为[68Ga]Ga-DOTATATE PET/CT用于鼻咽癌分期可能优于[68Ga]Ga-FAPI PET/CT。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to compare the staging efficiency of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in nasopharyngeal carcinoma (NPC) patients. METHODS: Thirty-nine patients with pathologically confirmed NPC were enrolled in this prospective study. Each patient underwent paired [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT on 2 successive days. The accuracy of two PET/CT for assessing T, N, and M stages was compared by using head-and-neck MRI, histopathologic diagnosis and follow-up results as reference standards. The radiotracer uptake derived from two PETs was also compared. RESULTS: For treatment-naïve patients, [68Ga]Ga-DOTATATE PET/CT showed identical sensitivity for the primary tumours but clearer tumor delineation induced by higher tumour-to-background (TBR) ratio (19.1 ± 8.7 vs. 12.4 ± 7.7, P = 0.003), compared with [68Ga]Ga-FAPI PET/CT. Regarding cervical lymph node (CLN) metastases, [68Ga]Ga-DOTATATE PET had significantly better sensitivity and accuracy based on neck sides (98% vs. 82%, P < 0.001; 99% vs. 88% P = 0.008), neck levels (98% vs. 78%, 99% vs. 97%; both P < 0.001) and individual nodes (89% vs. 56%, 91% vs. 76%; both P < 0.001), and higher TBR (8.1 ± 4.1 vs. 6.3 ± 3.7, P < 0.001). Additionally, [68Ga]Ga-DOTATATE PET/CT revealed higher sensitivity and accuracy for distant metastases (96% vs. 53%, 95% vs. 52%; both P < 0.001), particularly in bone metastases (99% vs. 49%, 97% vs. 49%; both P < 0.001). For post-treatment patients, [68Ga]Ga-DOTATATE PET/CT identified one more true-negative case than [68Ga]Ga-FAPI PET/CT. CONCLUSION: [68Ga]Ga-DOTATATE PET/CT performed better than [68Ga]Ga-FAPI PET/CT in visualizing the primary tumours, detecting the metastatic lesions and identifying the local recurrence, suggesting [68Ga]Ga-DOTATATE PET/CT may be superior to [68Ga]Ga-FAPI PET/CT for NPC staging.
引用
- Zheng J, Wang G, Ru Q, et al. A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study. Eur J Nucl Med Mol Imaging. 2024. PMID: 38724654. doi:10.1007/s00259-024-06744-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。